| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Adenocarcinoma (non-small cell lung cancer) | 1 | 0 | |
| Breast cancer | 1 | 1 | |
| Chronic myeloid leukemia | 1 | 0 | |
| Esophageal cancer | 1 | 0 | |
| Melanoma | 1 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 1 | |
| Mild | 0 | |
| None | 0 |